Allergy & Immunology Doctors in Peoria, IL Accepting Medicare

3 Allergy & Immunology doctors found. Showing 1 - 3

Dr. Stephen J Smart, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6615 N Big Hollow Rd, Peoria, IL 61615 Phone: 309-691-5200    Fax: 309-691-5201

Kenneth Arnett, Allergy & Immunology - Allergy Medicare: Medicare Enrolled Practice Location: 200 E Pennsylvania Ave, Peoria, IL 61603 Phone: 309-655-4184    Fax: 309-624-8876

Dr. Penelope A Ewbank, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6615 N Big Hollow Rd, Peoria, IL 61615 Phone: 309-691-5200    Fax: 309-691-5201

News Archive

Diabetes has negative impact on women's sex lives

Almost half of women in the US who suffer from Type 1 or 2 diabetes report that it has a negative impact on their sex lives, according to a new study released today by MicroMass Communications, Inc., a leader in behavioral marketing in the healthcare industry. The research, which highlighted the need for improved education and support to help women build confidence in their ability to overcome the challenges of the disease, was conducted with a representative sample of more than 800 women with diabetes.

Exposure to images of modified vulvas can significantly influence women's perceptions

Women's perceptions of what is considered normal and desirable female genitalia may be influenced by exposure to modified images, suggests a new study published today (20 December) in BJOG: An International Journal of Obstetrics and Gynaecology.

Survey results show significant positive impact on quality of care from use of PDAs in pediatric practice

Survey results released today in time for the American Academy of Pediatrics 2004 National Conference & Exhibition show significant positive impact on quality of care from use of PDAs in pediatric practice.

Potential new drug for lung cancer eliminates tumors in mice

A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer tumours from growing and becoming resistant to treatment. The authors of the research, from Imperial College London, are now planning to take the drug into clinical trials, to establish whether it could offer hope to patients with an inoperable form of lung cancer.

Aeterna Zentaris reports final results on clinical activity of perifosine for metastatic colorectal cancer

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, in combination with capecitabine (Xeloda) as a treatment for advanced, metastatic colorectal cancer.

Read more Medical News

› Verified 8 days ago